More than half a million Walgreens-branded eye drops are under recall after the maker could not assure sterility, an FDA Class II action covering nearly 750,000 products.
FOX Business reported that Sterling Pharmaceutical Services LLC, based in Dupo, Illinois, started the recall on Aug. 20 for a long list of eye-care items sold under several labels.
The U.S. Food and Drug Administration later ranked the action Class II on Sept. 21. That designation means use or exposure may cause temporary or medically reversible health problems, while the chance of serious harm is treated as remote.
Walgreens-branded products make up the bulk of the pullback, more than 500,000 units inside a wider recall of nearly 750,000 eye-care products.
Sterling Pharmaceutical Services LLC began the recall because of what an FDA enforcement report called a simple, serious failure.
The reason, per that report, was:
"lack of assurance of sterility"
Eye drops are not ordinary medicine. The FDA says drugs put on the eyes skip some of the body’s natural defenses, so the products must be sterile to cut infection risk.
That is why a sterility shortfall on lubricant drops and related eye-care goods draws a formal agency classification even when no injuries are listed in the available report.
The numbers attached to the Walgreens label are large. The recall covers about 301,114 bottles of Walgreens Lubricant Eye Drops and 199,600 twin packs under that brand.
Other labels sit in the same action. More than 120,000 packages of AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Lubricant Eye Drops are included, in single bottles and twin packs.
Also named are Reliable-1 Laboratories Sodium Chloride Hypertonicity Ophthalmic Solution 5% and Lubricating Tears; Cameron Pharmaceuticals Carboxymethylcellulose Sodium 0.5% Lubricant Eye Drops; TRP The Relief Products Gentle Eyes Lubricant Eye Drops; and Major LubriFresh P.M. Nighttime Ointment.
Together those brands push the overall count near 750,000 eye-care products.
Class II is not the FDA’s highest alarm. It still tells retailers and customers the products should leave shelves and medicine cabinets until the sterility question is closed.
No infections, injuries, or deaths tied to these specific lots appear in the FOX Business account of the enforcement report. The agency’s own Class II language still flags temporary or reversible health effects as possible.
A Walgreens representative did not immediately answer the outlet’s request for comment.
Lot lists, full distribution maps, and step-by-step return instructions were not laid out in the report as summarized. The core facts that are public are the initiator, the dates, the sterility reason, the Class II label, and the brand-level unit counts.
Eye drops are a daily habit for millions of Americans dealing with dry eyes, contacts, and aging vision. When a manufacturer in Illinois cannot assure sterility on products that land on Walgreens shelves and other labels, the people who pay at the register carry the risk.
Clean, sterile medicine is a baseline expectation, not a luxury, and recalls like this show how fast that baseline can slip when production controls fail.